Literature DB >> 8988664

Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images.

W L Wong1, K Hussain, E Chevretton, D J Hawkes, H Baddeley, M Maisey, M McGurk.   

Abstract

BACKGROUND: Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (PET-FDG) improves the detection of head and neck squamous cell cancer (HNSCC), but lacks anatomical detail. The accuracy of registered computed tomography/magnetic resonance (CT/MR) and PET-FDG in delineation of HNSCC at the primary site and its clinical application was investigated.
METHOD: Preoperatively 30 patients were staged clinically and each had either CT (23), MR (5), or both CT and MR (2) scans, as well as CT/MR-PET-FDG registration. Tumor margins or infiltration of specific anatomical landmarks on the different scans were compared and judged against histology.
RESULTS: For primary tumors CT-PET-FDG (97%) and MR-PET-FDG (100%) delineated the tumor more accurately than CT (69%) or MR (40%) alone. Similarly, CT-PET-FDG (98%) and MR-PET-FDG (100%) were better than CT (70%) and MR alone (80%) in identifying tumor invasion of specific anatomical structures. Management was altered in 7 of 30 patients. The registered images were particularly useful in delineating tumor extension in the infratemporal fossa, maxilla and mandible, and identifying recurrences obscured by scar tissue.
CONCLUSIONS: It is possible to accurately register CT, MR, and PET-FDG data sets in the head and neck. The initial results show that registered CT/ MR-PET-FDG images provide additional clinically relevant information over that obtained from clinical evaluation or conventional CT/MR imaging.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8988664     DOI: 10.1016/s0002-9610(96)00313-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

Review 1.  Management of lateral neck masses in adults.

Authors:  M Gleeson; A Herbert; A Richards
Journal:  BMJ       Date:  2000-06-03

2.  Image fusion for computer-assisted bone tumor surgery.

Authors:  Kwok Chuen Wong; Shekhar Madhuker Kumta; Gregory Ernest Antonio; Lung Fung Tse
Journal:  Clin Orthop Relat Res       Date:  2008-07-22       Impact factor: 4.176

Review 3.  Radiopharmaceuticals as probes to characterize tumour tissue.

Authors:  Israt S Alam; Mubarik A Arshad; Quang-Dé Nguyen; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

4.  TNM staging with FDG-PET/CT in patients with primary head and neck cancer.

Authors:  Patrick Veit-Haibach; Christopher Luczak; Isabel Wanke; Markus Fischer; Thomas Egelhof; Thomas Beyer; Gerlinde Dahmen; Andreas Bockisch; Sandra Rosenbaum; Gerald Antoch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-24       Impact factor: 9.236

Review 5.  18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.

Authors:  Eric C Ford; Joseph Herman; Ellen Yorke; Richard L Wahl
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

6.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-positive lymph node endometriosis masquerading as lymph node metastasis of a malignant tumor.

Authors:  Makoto Akiyama; Izumi Suganuma; Taisuke Mori; Izumi Kusuki; Haruo Kuroboshi; Fumitake Ito; Hiroshi Matsushima; Morio Sawada; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-10

7.  Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT.

Authors:  Rob H Ireland; Karen E Dyker; David C Barber; Steven M Wood; Michael B Hanney; Wendy B Tindale; Neil Woodhouse; Nigel Hoggard; John Conway; Martin H Robinson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-18       Impact factor: 7.038

8.  PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison.

Authors:  Sacha Rothschild; Gabriela Studer; Burkhardt Seifert; Pia Huguenin; Christoph Glanzmann; J Bernard Davis; Urs M Lütolf; Thomas F Hany; I Frank Ciernik
Journal:  Radiat Oncol       Date:  2007-06-09       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.